Suven Life Sciences Limited — Others, 05-06-2025: Shareholders meeting

Suven Life Sciences Limited has increased its authorized share capital and amended its Memorandum of Association to reflect this change. The company approved issuing up to 6.40 crore warrants convertible into equity shares within 18 months to promoter group entities and select non-promoter persons. Additionally, Smt. Sudharani Jasti was re-appointed as Whole-time Director. These decisions, supported strongly by shareholders through remote and electronic voting, may provide Suven with enhanced capital-raising flexibility and continuity in leadership.